Page last updated: 2024-10-15

phosphoserine and Bladder Cancer

phosphoserine has been researched along with Bladder Cancer in 1 studies

Phosphoserine: The phosphoric acid ester of serine.

Research Excerpts

ExcerptRelevanceReference
"Highly invasive bladder cancer cell lines, including T24, J82 and UM-UC-3 cells, showed increased uPAR mRNA expression and protein levels compared with the less aggressive cell lines, UROtsa and RT4."1.46mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer. ( Gilder, AS; Gonias, SL; Hansel, DE; Hau, AM; Hu, JJ; Leivo, MZ, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hau, AM1
Leivo, MZ1
Gilder, AS1
Hu, JJ1
Gonias, SL1
Hansel, DE1

Other Studies

1 other study available for phosphoserine and Bladder Cancer

ArticleYear
mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer.
    Cellular signalling, 2017, Volume: 29

    Topics: Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Cell Movement; Female; Gene Expression Regulation,

2017